72 related articles for article (PubMed ID: 16964477)
1. Adherence with allergen immunotherapy labeling guidelines.
Karam M; Samuels K; Holland C; Hernandez C; Greenhawt M
J Allergy Clin Immunol Pract; 2015; 3(2):250-5. PubMed ID: 25609334
[TBL] [Abstract][Full Text] [Related]
2. Allergy prevention.
Muche-Borowski C; Kopp M; Reese I; Sitter H; Werfel T; Schäfer T
Dtsch Arztebl Int; 2009 Sep; 106(39):625-31. PubMed ID: 19890407
[TBL] [Abstract][Full Text] [Related]
3. Starting the fight in the tumor: expert recommendations for the development of human intratumoral immunotherapy (HIT-IT).
Marabelle A; Andtbacka R; Harrington K; Melero I; Leidner R; de Baere T; Robert C; Ascierto PA; Baurain JF; Imperiale M; Rahimian S; Tersago D; Klumper E; Hendriks M; Kumar R; Stern M; Öhrling K; Massacesi C; Tchakov I; Tse A; Douillard JY; Tabernero J; Haanen J; Brody J
Ann Oncol; 2018 Nov; 29(11):2163-2174. PubMed ID: 30295695
[TBL] [Abstract][Full Text] [Related]
4. Success factors for adherence in hyposensitization.
Sondermann N; Shah-Hosseini K; Henkel K; Schwalfenberg A; Mösges R
Allergol Select; 2018; 2(1):89-93. PubMed ID: 31826036
[TBL] [Abstract][Full Text] [Related]
5. Safety aspects of subcutaneous immunotherapy with multiple allergens--a retrospective analysis on polysensitized patients.
Barth C; Anero F; Pfaar O; Klimek L; Hörmann K; Stuck BA
Eur Arch Otorhinolaryngol; 2010 Dec; 267(12):1873-9. PubMed ID: 20454971
[TBL] [Abstract][Full Text] [Related]
6. [Current recommendations for the use of SCIT and SLIT].
Lee H; Kleine-Tebbe J; Zuberbier T; Worm M
Hautarzt; 2006 Oct; 57(10):860-6. PubMed ID: 16964477
[TBL] [Abstract][Full Text] [Related]
7. [Allergens for specific immunotherapy: authorization and quality criteria of the Paul-Ehrlich-Institut].
May S; Kaul S; Schröder C; Vieths S
Hautarzt; 2006 Oct; 57(10):867-74. PubMed ID: 16977441
[TBL] [Abstract][Full Text] [Related]
8. [Cluster immunotherapy in allergic rhinoconjunctivitis: review of a new therapeutic approach].
Pfaar O; Klimek L
Hautarzt; 2006 Oct; 57(10):875-80. PubMed ID: 16969674
[TBL] [Abstract][Full Text] [Related]
9. [Role of allergen-specific immunotherapy (desensitization) for the treatment of allergies in Germany. Current situation].
Kleine-Tebbe J; Ackermann-Simon J; Hanf G
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2012 Mar; 55(3):343-50. PubMed ID: 22373847
[TBL] [Abstract][Full Text] [Related]
10. [Immunotherapy with allergen extracts for allergic rhinitis].
Riechelmann H
HNO; 2005 Jun; 53(6):517-20, 522-6, 528-30. PubMed ID: 15915345
[TBL] [Abstract][Full Text] [Related]
11. An evidence-based analysis of house dust mite allergen immunotherapy: a call for more rigorous clinical studies.
Calderon MA; Casale TB; Nelson HS; Demoly P
J Allergy Clin Immunol; 2013 Dec; 132(6):1322-36. PubMed ID: 24139829
[TBL] [Abstract][Full Text] [Related]
12. Prospective safety analysis of an ultrarush specific immunotherapy in adults with wasp venom allergy.
Lee H; Roediger C; Bauer A; Zuberbier T; Worm M
Allergy; 2006 Oct; 61(10):1237-8. PubMed ID: 16942578
[No Abstract] [Full Text] [Related]
13. Sublingual immunotherapy.
Heinzerling L; Worm M; Bergmann KC; Zuberbier T
J Dtsch Dermatol Ges; 2006 May; 4(5):428-33; quiz 434-5. PubMed ID: 16686612
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
